AAV Gene Therapy for MPS1-associated Corneal BlindnessMelisa Vance, Matthew L. Hirsch|Scientific Reports|2016Cited by 50
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapyBrian C. Gilger, Matthew L. Hirsch|Molecular Therapy|2024Cited by 9
AAV vector transduction restriction and attenuated toxicity in hESCs via a rationally designed inverted terminal repeatLiujiang Song, Matthew L. Hirsch|Nucleic Acids Research|2025Cited by 7